This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Adeona Executes WellZin™ Manufacturing And Supply Agreement

Stocks in this article: AEN

ANN ARBOR, Mich., Nov. 7, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), announced today that it has executed an agreement with F&F Foods of Chicago, Illinois, to provide commercial-scale manufacturing of wellZin™, the Company's oral zinc lozenge to reduce the duration and symptoms of the common cold. Adeona is planning to commercialize wellZin, a lozenge that contains 13.3 mg of zinc acetate, based on formulations clinically tested by Ananda S. Prasad, M.D., Ph.D., a Distinguished Professor of Internal Medicine at Wayne State University School of Medicine and an Adeona Scientific Advisory Board member. wellZin is intended to be a natural, safe and effective homeopathic over-the-counter (OTC) medicine for the common cold.

In July 2011, Adeona obtained exclusive access to statistically significant clinical data from two separate studies conducted by Dr. Prasad that evaluated the effectiveness of zinc acetate lozenges on the reduction of the duration and the symptoms of the common cold. Based upon findings from Dr. Prasad's two clinical studies[i],[ii] and his expertise as a pioneer in the field of zinc, he believes that many of the zinc preparations currently available on the market include a sub-optimal formulation and/or dose of zinc, and also include flavors and binders that diminish the effectiveness of zinc treatment for the common cold. In a February 15, 2011, New York Times article that referred to the recently published Cochrane Review of zinc for the common cold, Dr. Prasad was quoted as saying, "The public is confused because people have used the wrong dose, they have used the wrong sort of zinc or they have not started the treatment within 24 hours of onset."

"I am so excited to make wellZin commercially available for adults suffering from the symptoms of the common cold. When I notice cold symptoms coming on, it is the worst feeling and wellZin has the potential to cut the duration and the severity of symptoms of the common cold in half if you start taking it right away," stated James S. Kuo, M.D., M.B.A., Adeona's Chief Executive Officer. "That is why executing this agreement with F&F Foods for the manufacturing of wellZin is so important – it brings us one step for closer to commercialization."

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs